Uncategorized
Ozurdex effective for treatment of RVO in clinical practice
LONDON — Ozurdex demonstrated efficacy comparable to that demonstrated in other pivotal phase 3 clinical trials for the treatment of retinal vein occlusion, according to a presenter here.Jean-François Korobelnik, MD, presented the results of a multicenter, prospective study of the efficacy of Ozurdex (dexamethasone 0.7 mg intravitreal implant, Allergan) at the Euretina Congress.